Bavarian Nordic Revenue and Competitors
Estimated Revenue & Valuation
- Bavarian Nordic's estimated annual revenue is currently $285.2M per year.
- Bavarian Nordic's estimated revenue per employee is $155,000
Employee Data
- Bavarian Nordic has 1840 Employees.
- Bavarian Nordic grew their employee count by 21% last year.
Bavarian Nordic's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Snr VP, Global Operations | Reveal Email/Phone |
3 | Biosafety Officer | Reveal Email/Phone |
4 | Head Biostatistics | Reveal Email/Phone |
5 | Head Quality Control | Reveal Email/Phone |
6 | Head Global Distribution & Logistics | Reveal Email/Phone |
7 | Head North America Supply Chain | Reveal Email/Phone |
8 | Head Clinical Data Management | Reveal Email/Phone |
9 | VP, U.S. Government Affairs | Reveal Email/Phone |
10 | Controller, Goverment Reporting | Reveal Email/Phone |
Bavarian Nordic Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.9M | 77 | 7% | N/A | N/A |
#2 | $6221.7M | 40140 | -4% | N/A | N/A |
#3 | $2M | 13 | 0% | N/A | N/A |
#4 | $0.8M | 5 | -55% | N/A | N/A |
#5 | $2.8M | 18 | 6% | $11.1M | N/A |
#6 | $1M | 13 | -41% | N/A | N/A |
#7 | $1.7M | 11 | 0% | N/A | N/A |
#8 | $0.6M | 4 | 0% | N/A | N/A |
#9 | $5.9M | 38 | -5% | N/A | N/A |
#10 | $6.8M | 44 | 7% | N/A | N/A |
What Is Bavarian Nordic?
Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
keywords:N/A
N/A
Total Funding
1840
Number of Employees
$285.2M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bavarian Nordic News
2022-04-17 - Bavarian Nordic begins phase 3 clinical trial of MVA-BN RSV ...
A global, Phase 3 trial of approximately 20,000 older adult volunteers for the Bavarian Nordic A/S MVA-BN RSV vaccine candidate began this...
2022-04-17 - Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of
its RSV Vaccine Candidate in Older Adults
Bavarian Nordic's vaccine candidate, MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in older adults. The...
2022-03-30 - New Incentive Programs Established for Members of ...
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines.
Other Companies in Morrisville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $260.4M | 1860 | 10% | N/A |
#2 | $949.4M | 1921 | 87% | N/A |
#3 | $286.9M | 2009 | 12% | N/A |
#4 | $406.4M | 2022 | -35% | N/A |
#5 | $784M | 2074 | 16% | N/A |